β Common Receptor Mediates Erythropoietin-Conferred Protection on OxLDL-Induced Lipid Accumulation and Inflammation in Macrophages

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Lee, Tzong Shyuan ^a   Lu, Kuo Yun ^a   Yu, Yuan Bin ^a,b   Lee, Hsueh Te ^a   Tsai, Feng Chuan ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BETA COMMON RECEPTOR; ERYTHROPOIETIN; NEUTRALIZING ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CD131 ANTIGEN; CHOLESTEROL; CSF2RB1 PROTEIN, MOUSE; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL PROTECTION; CHOLESTEROL TRANSPORT; CONFOCAL MICROSCOPY; DIMERIZATION; FOAM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION; LIPID METABOLISM; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION; ANIMAL; CELL CULTURE; CHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION;

MUS;

ANIMALS; CELLS, CULTURED; CHOLESTEROL; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; ERYTHROPOIETIN; INFLAMMATION; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; MICE; PROTEIN MULTIMERIZATION;

EID: 84935879549     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/439759     Document Type: Article

References (55)

1. F. Stohlman Jr., S. Ebbe, B. Morse, D. Howard, and J. Donovan, "Regulation of erythropoiesis. XX. Kinetics of red cell production, " Annals of the New York Academy of Sciences, vol. 149, no. 1, pp. 156-172, 1968.
2. J. V. Brugniaux, "Erythropoietin: friend and foe!, " Acta Physiologica, vol. 212, no. 2, pp. 125-127, 2014.
3. L. Wang, L. Di, and C. T. Noguchi, "Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system, " International Journal of Biological Sciences, vol. 10, no. 8, pp. 921-939, 2014.
4. D. M. Bailey, C. Lundby, R. M. G. Berg, et al., "On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans, " Acta Physiologica, vol. 212, no. 2, pp. 175-187, 2014.
5. D. Burger, M. Lei, N. Geoghegan-Morphet, X. Lu, A. Xenocostas, and Q. Feng, "Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase, " Cardiovascular Research, vol. 72, no. 1, pp. 51-59, 2006.
6. K. Satoh, Y. Kagaya, M. Nakano, et al., "Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice, " Circulation, vol. 113, no. 11, pp. 1442-1450, 2006.
7. M. Choi, S. Y. Ko, I. Y. Lee, et al., "Carbamylated erythropoietin promotes neurite outgrowth and neuronal spine formation in association with CBP/p300, " Biochemical and Biophysical Research Communications, vol. 446, no. 1, pp. 79-84, 2014.
8. K. Pawlak, D. Pawlak, and M. Mysliwiec, "Long-term erythropoietin therapy decreases CC-chemokine levels and intimamedia thickness in hemodialyzed patients, " American Journal of Nephrology, vol. 26, no. 5, pp. 497-502, 2006.
9. Z. Cai, D. J. Manalo, G. Wei, et al., "Hearts fromrodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury, " Circulation, vol. 108, no. 1, pp. 79-85, 2003.
10. D. Ribatti, M. Presta, A. Vacca, et al., "Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo, " Blood, vol. 93, no. 8, pp. 2627-2636, 1999.
11. J. M. Al-Qahtani, B. A. Abdel-Wahab, and S. M. Abd El-Aziz, "Long-term moderate dose exogenous erythropoietin treatment protects from intermittent hypoxia-induced spatial learning deficits and hippocampal oxidative stress in young rats, " Neurochemical Research, vol. 39, no. 1, pp. 161-171, 2014.
12. K. C. Siamopoulos, C. Gouva, K. P. Katopodis, et al., "Longtermtreatmentwith EPO increases serumlevels of high-density lipoprotein in patients with CKD, " The American Journal of Kidney Diseases, vol. 48, no. 2, pp. 242-249, 2006.
13. K.-Y. Lu, L.-C. Ching, K.-H. Su, et al., "Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor β, " Circulation, vol. 121, no. 16, pp. 1828-1837, 2010.
14. A. I. Khan, S. M. Coldewey, N. S. A. Patel, et al., "Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor, " Disease Models & Mechanisms, vol. 6, no. 4, pp. 1021-1030, 2013.
15. S. M. Coldewey, A. I. Khan, A. Kapoor, et al., "Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor, " Kidney International, vol. 84, no. 3, pp. 482-490, 2013.
16. L. Sautina, Y. Sautin, E. Beem, et al., "Induction of nitric oxide by erythropoietin is mediated by the β common receptor and requires interaction with VEGF receptor 2, " Blood, vol. 115, no. 4, pp. 896-905, 2010.
17. K.-H. Su, S.-K. Shyue, Y. R. Kou, et al., " β common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase, " Journal of Cellular Physiology, vol. 226, no. 12, pp. 3330-3339, 2011.
18. M. Brines, G. Grasso, F. Fiordaliso, et al., "Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 41, pp. 14907-14912, 2004.
19. J. Wei, L.-C. Ching, J.-F. Zhao, et al., "Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis, " Acta Physiologica, vol. 207, no. 2, pp. 299-307, 2013.
20. C.-Y. Lin, T.-S. Lee, C.-C. Chen, et al., "Endothelin-1 exacerbates lipid accumulation by increasing the protein degradation of the ATP-binding cassette transporter G1 in macrophages, " Journal of Cellular Physiology, vol. 226, no. 8, pp. 2198-2205, 2011.
21. J.-F. Zhao, L.-C. Ching, Y. R. Kou, et al., "Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-κ-induced inflammation in macrophages: role of liver X receptor β, " Mediators of Inflammation, vol. 2013, Article ID 925171, 14 pages, 2013.
22. J.-F. Zhao, S.-J. Jim Leu, S.-K. Shyue, K.-H. Su, J. Wei, and T.-S. Lee, "Novel effect of paeonol on the formation of foam cells: promotion of LXRβ-ABCA1 dependent cholesterol efflux in macrophages, " American Journal of ChineseMedicine, vol. 41, no. 5, pp. 1079-1096, 2013.
23. F. Zheng, S. Xing, Z. Gong, et al., "Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein Edeficient mice, "Mediators of Inflammation, vol. 2014, Article ID 507208, 8 pages, 2014.
24. A. Pirillo, G. D. Norata, and A. L. Catapano, "LOX-1, OxLDL, and atherosclerosis, " Mediators of Inflammation, vol. 2013, Article ID 152786, 12 pages, 2013.
25. P. Shashkin, B. Dragulev, and K. Ley, "Macrophage differentiation to foam cells, " Current Pharmaceutical Design, vol. 11, no. 23, pp. 3061-3072, 2005.
26. M. Vinals, I. Bermudez, G. Llaverias, et al., "Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages, " Cardiovascular Research, vol. 66, no. 1, pp. 141-149, 2005.
27. N. S. Sabeva, C. M. McPhaul, X. Li, T. J. Cory, D. J. Feola, and G. A. Graf, "Phytosterols differentially influence ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells, " The Journal of Nutritional Biochemistry, vol. 22, no. 8, pp. 777-783, 2011.
28. J.-F. Zhao, S.-K. Shyue, S.-J. Lin, J. Wei, and T.-S. Lee, "Excess nitric oxide impairs LXR(β)-ABCA1-dependent cholesterol efflux in macrophage foam cells, " Journal of Cellular Physiology, vol. 229, no. 1, pp. 117-125, 2014.
29. M. Z. Ashraf and N. Gupta, "Scavenger receptors: implications in atherothrombotic disorders, " International Journal of Biochemistry and Cell Biology, vol. 43, no. 5, pp. 697-700, 2011.
30. C.-Y. Tsou, C.-Y. Chen, J.-F. Zhao, et al., "Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis, " Acta Physiologica, vol. 210, no. 4, pp. 799-810, 2014.
31. J.-F. Zhao, L.-C. Ching, Y.-C. Huang, et al., "Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis, " Molecular Nutrition and Food Research, vol. 56, no. 5, pp. 691-701, 2012.
32. C.-Y. Chen, S.-K. Shyue, L.-C. Ching, et al., "Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages, " The Journal of Nutritional Biochemistry, vol. 22, no. 11, pp. 1015-1021, 2011.
33. J.-Y. Tsai, K.-H. Su, S.-K. Shyue, et al., "EGb761 ameliorates the formationof foamcellsby regulating the expressionof SR-Aand ABCA1: role of haem oxygenase-1, " Cardiovascular Research, vol. 88, no. 3, pp. 415-423, 2010.
34. T.-S. Lee, C.-C. Pan, C.-C. Peng, et al., "Anti-atherogenic effect of berberine on LXRβ-ABCA1-dependent cholesterol efflux in macrophages, " Journal of Cellular Biochemistry, vol. 111, no. 1, pp. 104-110, 2010.
35. T.-S. Lee, C.-Y. Lin, J.-Y. Tsai, et al., "Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages, " Life Sciences, vol. 84, no. 3-4, pp. 97-104, 2009.
36. C.-Y. Chen, L.-C. Ching, Y.-J. Liao, et al., "Deficiency of glycine β-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice, "MolecularMedicine, vol. 18, no. 5, pp. 744-752, 2012.
37. L.-C. Cheng, K.-H. Su, Y. R. Kou, et al., "β-Lipoic acid ameliorates foam cell formation via liver X receptor β-dependent upregulation of ATP-binding cassette transporters A1 and G1, " Free Radical Biology and Medicine, vol. 50, no. 1, pp. 47-54, 2011.
38. X. Zhang, Q.-Y. Li, and B.-G. Xiao, "Anti-inflammatory effect of erythropoietin therapy on experimental autoimmune encephalomyelitis, " International Journal of Neuroscience, vol. 122, no. 5, pp. 255-262, 2012.
39. N. Ahmadiasl, S. Banaei, A. Alihemmati, B. Baradaran, and E. Azimian, "The anti-inflammatory effect of erythropoietin and melatonin on renal ischemia reperfusion injury in male rats, " Advanced Pharmaceutical Bulletin, vol. 4, no. 1, pp. 49-54, 2014.
40. N. Kertesz, J. Wu, T. H.-P. Chen, H. M. Sucov, and H. Wu, "The role of erythropoietin in regulating angiogenesis, " Developmental Biology, vol. 276, no. 1, pp. 101-110, 2004.
41. J. H. Holstein, M. Orth, C. Scheuer, et al., "Erythropoietin stimulates bone formation, cell proliferation, and angiogenesis in a femoral segmental defect model in mice, " Bone, vol. 49, no. 5, pp. 1037-1045, 2011.
42. K. A. S. Vilarinho, P. P. M. de Oliveira, M. J. A. Saad, et al., "Erythropoietin protects the systolic function of neonatal hearts against ischaemia/reperfusion injury, " European Journal Cardio-Thoracic Surgery, vol. 43, no. 1, pp. 156-162, 2013.
43. P. V. D. Meer, E. Lipsic, R. H. Henning, et al., "Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury, " European Journal of Heart Failure, vol. 6, no. 7, pp. 853859, 2004.
44. H. Ehrenreich, K. Weissenborn, H. Prange, et al., "Recombinant human erythropoietin in the treatment of acute ischemic stroke, " Stroke, vol. 40, no. 12, pp. e647-e656, 2009.
45. A. Phrommintikul, S. J. Haas, M. Elsik, and H. Krum, "Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis, " The Lancet, vol. 369, no. 9559, pp. 381-388, 2007.
46. V. Allegra, L. Martimbianco, and A. Vasile, "Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet, " Nephrology Dialysis Transplantation, vol. 12, no. 5, pp. 924-932, 1997.
47. C. A. Pollock, R. Wyndham, P. V. Collett, et al., "Effects of erythropoietin therapy on the lipid profile in end-stage renal failure, " Kidney International, vol. 45, no. 3, pp. 897-902, 1994.
48. M. Buemi, A. Allegra, F. Corica, et al., "Does erythropoietin administration affect progression of atherosclerosis in Watanabe heritable hyperlipaemic rabbits?" NephrologyDialysis Transplantation, vol. 13, no. 10, pp. 2706-2708, 1998.
49. F. T. Ruschitzka, R. H. Wenger, T. Stallmach, et al., "Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 21, pp. 11609-11613, 2000.
50. C. Moreau, R. Lariviere, I. Kingma, J. H. Grose, and M. Lebel, "Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats, " Clinical and Experimental Hypertension, vol. 22, no. 7-8, pp. 663-674, 2000.
51. M. Brines, N. S. A. Patel, P. Villa, et al., "Nonerythropoietic, tissue-protective peptides derived fromthe tertiary structure of erythropoietin, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 31, pp. 10925-10930, 2008.
52. F. Fiordaliso, S. Chimenti, L. Staszewsky, et al., "A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 6, pp. 2046-2051, 2005.
53. W. G. van Rijt, G. J. Nieuwenhuijs-Moeke, H. van Goor, et al., "ARA290, a non-erythropoieticEPOderivative, attenuates renal ischemia/reperfusion injury, " Journal of TranslationalMedicine, vol. 11, no. 1, article 9, 8 pages, 2013.
54. W. G. Van Rijt, G. J. Nieuwenhuijs-Moeke, H. Van Goor, P. J. Ottens, R. J. Ploeg, and H. G. D. Leuvenink, "Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury, " Journal of Translational Medicine, vol. 11, no. 1, article 286, 2013.
55. K.-H. Su, Y.-B. Yu, H.-H. Hou, et al., "AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase, " Journal of Cellular Physiology, vol. 227, no. 8, pp. 3053-3062, 2012.